SUMMARY Gastric alkaline secretion was determined in ranitidine treated healthy subjects and duodenal ulcer (DU) patients using gastric perfusion aspiration system and back titration of gastric perfusate to original pH 6-0. Basal alkaline secretion showed periodic fluctuations reaching peaks at phase III of the migrating motor complex (MMC) in the stomach. Mean basal alkaline secretion in healthy normals and DU patients averaged 1120±124 and 880±72 ,umol/h, respectively and no correlation was found between basal and maximally stimulated gastric acid and alkaline secretion. Modified sham feeding in normal subjects and in DU patients increased this secretion to the peaks of about 28 and 36% of the maximal alkaline response to intragastric application of 16,16 dimethyl-PGE2 in these subjects. Vagotomy did not affect significantly basal alkaline secretion but prevented the rise in alkaline secretion induced by modified sham feeding. Atropine (5-20 [igIkg) decreased dose dependently basal, and prevented the modified sham feeding induced alkaline secretion, while pirenzepine (5-20 ,tg/kg) had little influence on basal, and did not affect the modified sham feeding induced, alkaline secretion. This study shows that basal gastric alkaline secretion fluctuates in phase with gastric motor activity, and is similar in normal and DU patients. Vagal stimulation strongly increases alkaline secretion, the effect being abolished by vagotomy and atropine, but not by pirenzepine, suggesting the involvement of M2 rather than Ml subtypes of muscarinic receptors in this stimulation.
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Alkaline secretion of the gastroduodenal mucosa has been shown in various species, including man, to be an active process contributing to the mucosal defence mechanisms, particularly against luminal acid.R ecent studies in dogs revealed that alkaline secretion in fasted dogs fluctuates in phase with motor activity4 and increases after vagal stimulation.5
Studies in man confirmed similar increase in gastric alkaline secretion after sham feeding67 and its suppression after the administration of anticholinergics, suggesting that vagal cholinergic component plays an important role in the mechanism of this secretion.
This study was undertaken (1) to determine the magnitude and possible fluctuations of basal alkaline secretion with respect to gastric motor activity; (2) The experiments were carried out after an overnight fast. In the evening of the day before the examination and the morning, about two hours before the experiment, subjects ingested 900 mg ranitidine (Glaxo, England) with water. In all tests during the examination, ranitidine was infused intravenously at a dose of 50 mg/h throughout the experiment. Such pretreatment resulted in a complete suppression of gastric acid secretion (luminal pH 7-0 or above) and prevented any conversion of HCO3 to CO2.9
Double lumen gastroduendal Dreiling tube with endotracheal cuff was inserted and positioned under fluoroscopic control with the cuff inflated just distally to the pylorus to prevent any escape of gastric perfusate into the duodenum or any reflux of the duodenal content into the stomach as described before.9 The tube with openings located in the distal portion of the stomach was used to continuously aspirate gastric content. An additional polyethylene catheter attached to the tube with openings in the proximal part of the stomach was used to perfuse the stomach with saline adjusted to pH 6-0 and containing phenol red as a non-absorbable marker (40 Ftg/ml). The rate of gastric perfusion was 600 ml/h. The perfusion-aspiration procedure was carried out throughout the examination. The volume of gastric perfusate was measured and the bicarbonate content was determined by back titration of the gastric perfusate to original pH (6.0) as described pre- viously."' The samples of the perfusates were saved for phenol red determination (by spectrophotometry at 520 nm after being alkalinised to pH 11-5) and for PGE2 radioimmunoassay as described before."
In some studies the motor activity of the stomach was monitored by means of perfused manometric catheter attached to the Dreiling tube with wide side openings located in the gastric antrum. Measurements were carried out using technique described before" during alkaline secretion and after modified sham feeding with subsequent administration of 16, 16DMPGE2.
EXPERIMENTAI1 DESIGN
Several series of secretory tests were carried out. In the basal-MSF-PGE2 experiments (series A), 60-120 min of basal collection and motility recordings were carried out in all subjects of this group followed by 15 minutes of the modified sham feeding during which the subjects were given roast beef and French fries as described." Gastric perfusion-aspiration procedure was continued for 90 minutes after modified sh'am feeding. Finally, 16,16- then showed a small but insignificant rise during phase II to reach significant (over phase I value) peak at phase III ('activity front') when the rate of gastric contractions reached the peak (about 3/min). The mean interval between two consecutive gastric activity fronts averaged 94±6 minutes in healthy subjects and it was similar to that in DU patients (88±10 min). The mean values of gastric contractions and gastric alkaline secretion in all healthy subjects tested during one MMC cycle are shown on Figure 1 .
No significant correlation was found between basal sham feeding-induced alkaline secretion was similar to that recorded in other patients with inactive peptic ulcer (series C). After vagotomy, basal alkaline secretion was unchanged but modified sham feeding failed to increase this secretion (Fig. 5) . Intragastric administration of PGE2 analog resulted in similar increase in gastric alkaline secretion as before the vagotomy and these results are not included. In all these subjects, vagotomy was complete as judged by insulin tests performed about 10 days before the examination.
Discussion significantly This study shows that in man, basal gastric alkaline tion induced secretion fluctuates in phase with gastric motor analogue and activity reaching peaks at the phase III of MMC and clarity.
markedly increases after vagal stimulation to reach nd modified about 30% of the maximal alkaline response to exogenous PGE2. 16 According to our results, the rate of alkaline secretion is not constant but shows cyclic fluctuations reaching peaks at phase III of the gastric MMC. Such periodic fluctuations of gastric acid or pancreatic enzyme secretion were reported previously in man but this study described for the first time that gastric alkaline secretion is also in close relation to gastric motility. The mechanism of the secretory and motor periodicity of the digestive functions remains unclear but both neural and endocrine factors have been implicated.. '8 There is little doubt that vagal cholinergic component contributes to the gastric alkaline secretion. Our finding that atropine reduces dose dependently basal alkaline secretion without affecting the secretory stimulation by exogenous PGE2 suggests that basal cholinergic drive has a substantial influence on alkaline secretion. This drive is probably of local intramural origin because it remained unchanged after complete vagotomy. On the other hand, vagal nerves appear to have a potent stimulatory influence on alkaline secretion as shown by a marked rise in this secretion after physiological vagal excitation such as sham feeding7 and almost complete removal of this excitation by vagotomy. The mechanism of the modified sham feeding-induced HCO3 secretion is unknown. As modified sham feeding increased the release of plasma gastrin and PP, which are under vagal-cholinergic control and which were shown to stimulate HCO3 in dogs,'9 we carried out separate tests to determine whether these gut hormones could contribute to the vagally stimulated HCO3 secretion. Unlike in dogs,'9 neither gastrin nor polypeptide affected gastric HCO3 secretion indicating that the vagally induced HCO3 in man does not depend upon the action of those hormones. The vagal-cholinergic stimulation of gastric alkaline secretion was accompanied by a significant increase in luminal release of PGE2 but it appears to be independent from that induced by PGE2 as neither atropine nor vagotomy affected the secretory stimulation by PGE2. It is of interest, that vagally stimulated gastric alkaline secretion, as well as vagally induced acid secretion did not reach the maximal secretory capacity elicited by PGE2 and pentagastrin, respectively. This could be explained that modified sham feeding is only a submaximal stimulus for gastric acid-alkaline secretion or that both stimulatory and inhibitory mechanisms are activated simultaneously by vagal activation.'
It is of interest that vagal-cholinergic component of gastric alkaline secretion is not blocked by pirenzepine, a highly specific antimuscarinic agent acting via M muscarinic receptors.2'2' Our finding that pirenzepine does not interfere with basal or vagally stimulated alkaline secretion may explain the well characterised gastroprotective2' and antiulcer activity2"122 of this drug. Benzilonium bromide another anticholinergic, was reported to abolish modified sham feeding induced alkaline secretion as did atropine, but failed to affect basal alkaline secretion.7 This suggests that various anticholinergics act on alkaline secretion via different mechanisms and various subtypes of muscarinic receptors.
